Sector: MedicalEli Lilly and Company (NYSE: LLY)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 233 |
Technical : | 102 |
Performance : | 187 |
Overall: | 199 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 230 |
Technical : | 10 |
Performance : | 205 |
Overall: | 152 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 229 |
Technical : | 3 |
Performance : | 243 |
Overall: | 182 |
Number of Stocks: | 306 |
Headlines
- Analyst Choice Initiates Market Analysis on Healthcare, Technology and Consumer Goods Sectors
Nov 20, 2009 08:14 AM | HSP, IP, LLY, SQNM, TEL, TYC
- Karen B. Dow Joins Sughrue Mion's San Diego Office
Nov 19, 2009 09:35 AM | LLY
- LILLY (ELI) & COMPANY - Effient Recommendations in PCI-STEMI Guidelines
Nov 18, 2009 01:34 PM | LLY
- A Winning Investment Strategy
Nov 18, 2009 11:44 AM | ABT, ADP, AFL, CVX, DOV, EMR
- Growing Cross-Industry Demand for HPC and Cloud Computing Fuels Cycle Computing's Rapid Expansion
Nov 17, 2009 01:02 PM | IT, LLY, PFE, VARI
- LILLY (ELI) & COMPANY - Research Update
Nov 16, 2009 08:27 AM | LLY
- Lilly Surpasses United Way 2009 Campaign Goal
Nov 16, 2009 08:15 AM | LLY
- Efient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
Nov 15, 2009 03:01 PM | LLY
- Effient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
Nov 15, 2009 03:00 PM | LLY
- Fitch Revises Eli Lilly & Co.'s Outlook to Negative
Nov 13, 2009 09:47 AM | LLY
- Being green isn't new marketing - it's good, established business
Nov 15, 2009 03:52 AM | LLY
- BioMS Medical Announces Third Quarter 2009 Results
Nov 12, 2009 05:53 PM | LLY
- Google, Yahoo call for expanded online drug ads
Nov 12, 2009 02:56 PM | LLY, PFE
- The Indianapolis Star Daniel Lee Column: Indiana Working to Create Its Own Identity With Investors
Oct 25, 2009 11:53 AM | LLY, VC
- Eli Lilly to pay S. Carolina $45 million
Oct 24, 2009 02:43 PM | LLY
- Lilly Q3 Net Income Up
Oct 23, 2009 12:54 PM | LLY
- Eli Lilly CEO banking on new drug pipeline
Oct 22, 2009 01:54 PM | LLY, PFE
- Earnings Preview: Bristol-Myers 3Q earnings report
Oct 21, 2009 11:53 AM | AZN, BMY, GSK, JNJ, LLY, MRK
- The Business Diary
Oct 19, 2009 01:55 AM | AMGN, BA, FRX, LLY, MTB, NTRS
- Drug makers, CVS slammed for promos
Oct 18, 2009 05:47 PM | AZN, CVS, LLY, MRK
- Analyst Choice Initiates Market Analysis on Healthcare, Technology and Consumer Goods Sectors
Nov 20, 2009 10:18 AM | HSP, IP, LLY, SQNM, TEL, VIP
- ConocoPhillips up 21% Since Added to Galtstock Long-Term Portfolio
Nov 05, 2009 11:53 AM | COP, LLY, RIG, WMT
- Phase Forward Reports Third Quarter 2009 Results
Oct 29, 2009 04:56 PM | AGN, AZN, CVD, LLY, PFWD, PG
- Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter
Oct 22, 2009 07:51 AM | AZN, BMY, GILD, LLY
- Licensing Executives Society Announces 2009 Deals of Distinction Awards
Oct 21, 2009 03:52 PM | AGN, LLY, UTHR
- Best Practices to Speed-Up Pharmaceutical Analysis Processes From Johnson & Johnson, Pfizer, Genentech and Eli Lilly at Pharma IQ's Forum on Laboratory Informatics
Sep 30, 2009 11:58 AM | JNJ, LLY, PFE
- PHT Corporation Promotes Dwight Cooper to Vice President of Client Services
Sep 24, 2009 09:57 AM | LLY
- Teva Provides Update on Generic Evista® Litigation
Sep 24, 2009 06:54 AM | LLY, TEVA
- Deltagen Reports 2009 Second Quarter Financial Results
Sep 18, 2009 07:51 PM | LLY, PFE
- Transition Therapeutics Announces Fiscal 2009 Year End Financial Results
Sep 16, 2009 04:53 PM | LLY, TTHI
- Form 3/A LILLY ELI & CO For: May 01 Filed by: Mahony Susan (10K)
Nov 12, 2009 09:55 AM
- Form 3 Johnson John H For: Nov 01 (10K)
Nov 10, 2009 01:22 PM
- Form 3 Conterno Enrique A For: Nov 01 (10K)
Nov 10, 2009 01:18 PM
- Form 4 HOOVER R DAVID For: Oct 30 (10K)
Nov 02, 2009 10:08 AM
- Form 4 Fyrwald J Erik For: Oct 30 (10K)
Nov 02, 2009 10:04 AM
- Form 4 HOOVER R DAVID For: Aug 31 (10K)
Aug 31, 2009 11:39 AM
- Form 4 Fyrwald J Erik For: Aug 31 (10K)
Aug 31, 2009 11:35 AM
- Form 4 HOOVER R DAVID For: Jul 31 (10K)
Aug 03, 2009 12:56 PM
- Form 4 Fyrwald J Erik For: Jun 30 (10K)
Jul 01, 2009 02:14 PM
- Form 3 Peterson Barton R For: Jun 15 (10K)
Jun 19, 2009 05:57 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
LLY
|
Compare to S&P
|
| YTD |
-12.19 %
|
-27.47 %
|
| 4 Weeks |
2.67 %
|
2.13 %
|
| 12 Weeks |
5.71 %
|
-0.80 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 7.14 %
|
|
EPS Growth in Last Year: 15.38 %
|
|
Sales Growth in Last Quarter: 5.09 %
|
|
Sales Growth in Last Quarter: 6.77 %
|
|
